2010 Gynecologic Cancer InterGroup (GCIG) Consensus Statement on Clinical Trials in Ovarian Cancer: Report From the Fourth Ovarian Cancer Consensus Conference-Reference-Cited by-同舟云学术

2010 Gynecologic Cancer InterGroup (GCIG) Consensus Statement on Clinical Trials in Ovarian Cancer: Report From the Fourth Ovarian Cancer Consensus Conference

Published:2011-04 Issue:4 Volume:21 Page:750-755
ISSN:1048-891X
Container-title:International Journal of Gynecologic Cancer
language:en
Short-container-title:Int J Gynecol Cancer

Author:

Stuart Gavin C.E.,Kitchener Henry,Bacon Monica,duBois Andreas,Friedlander Michael,Ledermann Jonathan,Marth Christian,Thigpen Tate,Trimble Edward

Abstract

2010 Gynecologic Cancer InterGroup (GCIG) consensus statement on clinical trials in ovarian cancer. This report provides the outcomes from the Fourth Ovarian Cancer Consensus Conference.

Publisher

BMJ

Subject

Obstetrics and Gynaecology,Oncology

Reference8 articles.

1. Advanced epithelial ovarian cancer: 1993 consensus statements

2. 2004 consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004)

3. History, scope and methodology of the 3rd International Consensus Workshop on Ovarian Cancer 2004

4. Dose-dense paclitaxel once a week in combination with carboplatin every 3 weeks for advanced ovarian cancer: a phase 3, open-label, randomised controlled trial

Cited by 364 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. British Gynaecological Cancer Society (BGCS) ovarian, tubal and primary peritoneal cancer guidelines: Recommendations for practice update 2024;European Journal of Obstetrics & Gynecology and Reproductive Biology;2024-09

2. MicroRNA-486-3p affects cisplatin resistance in high-grade serous ovarian cancer by regulating TMIGD2: An experimental study;Heliyon;2024-08

3. Poly (ADP-ribose) polymerase inhibitor therapy and mechanisms of resistance in epithelial ovarian cancer;Frontiers in Oncology;2024-07-29

4. External validation of Standardized KELIM and platinum-resistant recurrence scores in patients with advanced epithelial ovarian cancer;Journal of Ovarian Research;2024-07-22

5. ESR Essentials: characterisation and staging of adnexal masses with MRI and CT—practice recommendations by ESUR;European Radiology;2024-06-07